Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9024-9033

  Zhang, Zhen ^a   Rowe, Jenny ^b   Wang, Weijia ^a   Sommer, Marvin ^c   Arvin, Ann ^c   Moffat, Jennifer ^b   Zhu, Hua ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; LUCIFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE VECTOR; GENETIC ANALYSIS; GROWTH CURVE; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MUTAGENESIS; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCID MOUSE; VALIDATION PROCESS; VARICELLA ZOSTER VIRUS; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DISEASE MODELS, ANIMAL; GENE DELETION; GENES, ESSENTIAL; GENETIC VECTORS; GENOME, VIRAL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; LUCIFERASES; MICE; MICE, SCID; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; STAINING AND LABELING; VIRAL PROTEINS; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 3; MUS;

EID: 34548162329     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02666-06     Document Type: Article

References (34)

1. Arvin, A. M. 2001. Varicella-zoster virus, p. 2731-2767. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Ball, K. D., and J. T. Trevors. 2002. Bacterial genomics: the use of DNA microarrays and bacterial artificial chromosomes. J. Microbiol. Methods 49:275-284.
3. Besser, J., M. H. Sommer, L. Zerboni, C. P. Bagowski, H. Ito, J. Moffat, C.-C. Ku, and A. M. Arvin. 2003. Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J. Virol. 77:5964-5974.
4. Boehncke, W. H. 1999. The SCID-hu xenogeneic transplantation model: complex but telling. Arch. Dermatol. Res. 291:367-373.
5. Cohen, J. I., T. Krogmann, J. P. Ross, L. Pesnicak, and E. A. Prikhod'ko. 2005. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. J. Virol. 79:6969-6975.
6. Cohen, J. I., and K. E. Seidel. 1993. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. USA 90:7376-7380.
7. Cohen, J. I., and K. E. Seidel. 1995. Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro. Virology 206:835-842.
8. Cohen, J. I., and S. E. Straus. 2001. Varicella-zoster virus and its replication, p. 2707-2730. In D. M. Knipe and P. M. Howley (ed.), Fields virology, vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
9. Doyle, T. C., S. M. Burns, and C. H. Contag. 2004. In vivo bioluminescence imaging for integrated studies of infection. Cell Microbiol. 6:303-317.
10. Gilden, D. H., B. K. Kleinschmidt-DeMasters, J. J. LaGuardia, R. Mahalingam, and R. J. Cohrs. 2000. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342:635-645.
11. Hambleton, S., and A. A. Gershon. 2005. Preventing varicella-zoster disease. Clin. Microbiol. Rev. 18:70-80.
12. Kemble, G. W., P. Annunziato, O. Lungu, R. E. Winter, T.-A. Cha, S. J. Silverstein, and R. R. Spaete. 2000. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J. Virol. 74:11311-11321.
13. Ku, C.-C., J. Besser, A. Abendroth, C. Grose, and A. M. Arvin. 2005. Varicella-zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J. Virol. 79:2651-2658.
14. Mallory, S., M. Sommer, and A. M. Arvin. 1997. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71:8279-8288.
15. Marchini, A., H. Liu, and H. Zhu. 2001. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol. 75:1870-1878.
16. Moffat, J. F., and A. M. Arvin. 1999. Varicella-zoster virus infection of T cells and skin in the SCID-hu mouse model, p. 973-980. In M. A. Sande and O.
17. Zak (ed.), Handbook of animal models of infection: experimental models in antimicrobial chemotherapy. Academic Press, San Diego, CA.
18. + T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
19. Nagaike, K., Y. Mori, Y. Gomi, H. Yoshii, M. Takahashi, M. Wagner, U. Koszinowski, and K. Yamanishi. 2004. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 22:4069-4074.
20. Nash, T. C., and J. G. Spivack. 1994. The UL55 and UL56 genes of herpes simplex virus type 1 are not required for viral replication, intraperitoneal virulence, or establishment of latency in mice. Virology 204:794-798.
21. Netterwald, J., S. Yang, W. Wang, S. Ghanny, M. Cody, P. Soteropoulos, B. Tian, W. Dunn, F. Liu, and H. Zhu. 2005. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J. Virol. 79:5035-5046.
22. Niizuma, T., L. Zerboni, M. H. Sommer, H. Ito, S. Hinchliffe, and A. M. Arvin. 2003. Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J. Virol. 77:6062-6065.
23. Rice, B. W., M. D. Cable, and M. B. Nelson. 2001. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6:432-440.
24. Sato, B., H. Ito, S. Hinchliffe, M. H. Sommer, L. Zerboni, and A. M. Arvin. 2003. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J. Virol. 77:5607-5620.
25. Sato, B., M. Sommer, H. Ito, and A. M. Arvin. 2003. Requirement of varicella-zoster virus immediate-early 4 protein for viral replication. J. Virol. 77:12369-12372.
26. Sato, H., L. Pesnicak, and J. I. Cohen. 2002. Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency. J. Virol. 76:3575-3578.
27. Shiraki, K., Y. Yoshida, Y. Asano, K. Yamanishi, and M. Takahashi. 2003. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts. J. Infect. Dis. 188:1875-1877.
28. Swaminathan, S., H. M. Ellis, L. S. Waters, D. Yu, E. C. Lee, D. L. Court, and S. K. Sharan. 2001. Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis 29:14-21.
29. Takahashi, M., T. Otsuka, Y. Okuno, Y. Asano, and T. Yazaki. 1974. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288-1290.
30. Taylor, S. L., and J. F. Moffat. 2005. Replication of varicella-zoster virus in human skin organ culture. J. Virol. 79:11501-11506.
31. Volpi, A. 2005. Varicella immunization and herpes zoster. Herpes 12:59.
32. Wang, W., C. E. Patterson, S. Yang, and H. Zhu. 2004. Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. J. Virol. Methods 121:137-143.
33. Yu, D., H. M. Ellis, E. C. Lee, N. A. Jenkins, N. G. Copeland, and D. L. Court. 2000. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. Sci. USA 97:5978-5983.
34. Zerboni, L., C. C. Ku, C. D. Jones, J. L. Zehnder, and A. M. Arvin. 2005. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. USA 102:6490-6495.